Kimberly Yonkers, MD:  RECENT PUBLICATIONS (Peer Reviewed)

1. Kornstein SG, Schatzberg AF, Thase ME, Yonkers KA, McCullough JP, Keitner GI, Gelenberg AJ, Ryan CE, Hess AL, Harrison W, Davis SM, Keller MB. Gender differences in chronic major and double depression, Journal of Affective Disorders, 2000; 60(1), 1-11.

2. Yonkers KA, Dyck I, Warshaw M, Keller MB.  Factors predicting the clinical course of generalized anxiety disorder.  British Journal of Psychiatry, 2000; 176: 544-550.

3. Kornstein SG, Schatzberg AF, Thase ME, Yonkers KA, McCullough JP, Keitner GI, Gelenberg AJ, Davis SM, Keller MB. Gender differences in treatment response to sertraline versus imipramine in chronic depression, American Journal of Psychiatry, 2000; 157:1445-1452. 

4.  Pearlstein TB, Halbreich U, Batzar ED, Brown CS, Endicott J, Frank E, Freeman EW, Harrison WM, Haskett RF, Stout AL, Yonkers KA. Psychosocial Functioning in Women with Premenstrual Dysphoric Disorder Before and After Treatment with Sertraline or Placebo. Journal of Clinical Psychiatry, 2000; 61: 101-109.

5.   ADDIN ENBbu Yonkers KA, Dyck IR, Keller MB: An eight year longitudinal comparison of clinical course and characteristics of social phobia among men and women. Psychiatric Services, 2001; 52(5):637-643.

6.  Yonkers KA, Ramin SM, Rush AJ, Navarrette CA, Carmody T, March D, Heartwell SF, Leveno KJ: Presence and persistence of postpartum depression in an inner-city maternal health system. American Journal of Psychiatry, 2001; 158: 1856-1863

7.  Freeman, E, Rickels K, Yonkers KA, Kunz N, McPherson M: Venlafaxine in the Treatment of Premenstrual Dysphoric Disorder. Obstetrics & Gynecology, 2001; 98 (5), 737-744.

8.  Rapaport MH, Judd LL, Schettler PJ, Yonkers KA, Thase ME, Kupfer DJ, Frank E, Plewes JM, Tollefson GD, Rush AJ: A descriptive analysis of minor depression. American Journal of Psychiatry, 2002; 159 (4): 637-643

9.  Halbreich U, Bergeron R, Yonkers KA, Freeman E, Stout AL, Cohen L. Efficacy of intermittent, luteal phase sertraline treatment of premenstrual dysphoric disorder. Obstetrics & Gynecology, 2002; 100: 1219-1229

10.  Yonkers KA, Brawman-Mintzer O. The Pharmacological Treatment of Depression: Is Gender A Critical Factor? Journal of Clinical Psychiatry 2002; 63 (7): 610-615

11.  Pearlstein T, Yonkers KA: Review of fluoxetine and its clinical applications in premenstrual dysphoric disorder. Expert Opinion in Pharmacotherapy, 2002; 3 (7), 979-991.

12.  Altshuler L, Richards M, Yonkers KA: Treating bipolar disorder during pregnancy, Current Psychiatry, 2003; 2(7):14-26

13.  Steiner M, Yonkers KA: Evidence-based treatment of mood disorders in women, Mental Fitness, 2003; 2(3): 34-67

14.  Yonkers KA, Bruce SE, Dyck IR, Keller MB: Chronicity, Relapse and Illness, Course of Panic Disorder, Social Phobia and Generalized Anxiety Disorder: Findings in Men and Women from 8 Years of Follow Up, Depression and Anxiety, 2003, 17: 173-179.

15.  Borenstein JE, Dean B, Endicott J, Wong J, Brown C, Dickerson V, Yonkers KA. The Health and economic impact of premenstrual syndrome. The Journal of Reproductive Medicine, 2003; 48 (7): 515-524.

16.  Yonkers KA, Pearlstein T, Rosenheck R. Premenstrual disorders: Bridging research and clinical reality. Archives of Women’s Mental Health, 2003; 6 (4); 287-292.

17.  Smith M, Cavaleri MA, Howell HB, Poschman K, Rosenheck RA, Yonkers KA:  Screening for and detection of depression, panic disorder and PTSD in public sector obstetrical clinics.  Psychiatric Services, 2004; 55 (4): 407-414.

18. Judd LJ, Rapaport MH, Yonkers KA, Rush AJ, Frank E, Thase ME, Kupfer DJ, Plewes JM, Schettler PJ, Tollefson G: Randomized, placebo-controlled trial of fluoxetine for acute treatment of minor depressive disorder. The American Journal of Psychiatry, 2004; 161 (10): 1864-1871.

19.  Perkonigg A, Yonkers KA, Pfister H, Lieb R, Wittchen H-U. Risk factors for premenstrual dysphoric disorder in a community sample of young women: The role of traumatic events and posttraumatic stress disorder. The Journal of Clinical Psychiatry, 2004; 65 (10): 1314-1322.

20.  Cohen LS, Soares CN, Yonkers KA, Bellew KM, Bridges IM, Steiner M. Paroxetine controlled release for premenstrual dysphoric disorder: A double-blind, placebo-controlled trial. Psychosomatic Medicine, 2004; 66 (5): 707-713.

21.  Yonkers KA, Smith M, Brunetto WL, Cavaleri MA:  Recognizing depression in gynecologic patients. Contemporary Obstetrics and Gynecology, 2004; 49 (6)

22.  Yonkers KA, Wisner K, Stowe Z, Leibenluft E, Cohen L, Miller L, Manber R, Viguera A, Suppes T, Altshuler L.  Management of bipolar disorder during pregnancy and the postpartum period. American Journal of Psychiatry, 2004; 161(4) :608-620.

23.  Smith M, Brunetto WL, Yonkers KA:  Identifying perinatal depression--sooner is better. Contemporary Obstetrics and Gynecology, 2004; 49 (4)

24.  Yonkers KA, Pearlstein T, Fayyad R, Gillespie JA: Luteal phase treatment of premenstrual dysphoric disorder (PMDD) improves symptoms that continue into postmenstrual phase. Journal of Affective Disorders, 2005; 85 (3): 317-321.

25.  Pearlstein T, Yonkers KA, Fayyad R, Gillespie JA: Pretreatment pattern of symptom expression in premenstrual dysphoric disorder. Journal of Affective Disorders, 2005; 85: 275-282.

26.  Bruce SE, Yonkers KA, Otto MW, Eisen JL, Weisberg RB, Pagano M, Shea MT, Keller MB: Influence of psychiatric comorbidity on recovery and recurrence in generalized anxiety disorder, social phobia, and panic disorder: a 12-year prospective study, American Journal of Psychiatry, 2005;162 (6):1179-87.

27.  Yonkers KA, Brown C, Pearlstein TB, Foegh M, Sampson-Landers C, Rapkin A. Efficacy of a New Low-Dose Oral Contraceptive With Drospirenone in Premenstrual Dysphoric Disorder. Obstetrics & Gynecology, 2005 106: 492-501.

28.  Pearlstein T, Bachmann GA, Zacur HA, Yonkers, KA.  Treatment of premenstrual dysphoric disorder with a new drospirenone-containing oral contraceptive formulation.  Contraception, 2005;  73: 414- 421..

29.  Smith MV, Poschman, KP, Allen AA, Cavaleri MA, Howell HB, Yonkers KA. Symptom
    Profiles of PTSD in Pregnancy. American Journal of Psychiatry, 2006, 163, pp 881-884.

30.  Yonkers KA, Holthausen GA, Poschman K, Howell HB.  Symptom onset treatment for women with premenstrual dysphoric disorder. Journal of Clinical Psychopharmacology. 2006, 26:198-202.

31.  Dean BB, Borenstein JE, Knight K and Yonkers KA:  Evaluating the Criteria Used for the Identification of PMS, Journal of Women’s Health, 2006, 15 (5):546-555.

32.  Halbreich U, Backstrom T, Eriksson E, O'Brien S, Calil H, Ceskova E, Dennerstein L, Douki S, Freeman E, Genazzani A, Heuser I, Kadri N, Rapkin A, Steiner M, Wittchen HU. Yonkers KA. Clinical diagnostic criteria for premenstrual syndrome and guidelines for their quantification for research studies. Gynecological Endocrinology, 2007, 23 (3):123-130.

33.  Borenstein JE, Dean BB, Yonkers KA, Endicott J. Using the daily record of severity of problems as a screening instrument for premenstrual syndrome, Obstetrics & Gynecology. 2007, 109 (5):1068-75.

Recent Editorials, Reviews, Chapters, Books

1.  Steiner M, Yonkers KA, Eriksson E (eds): Mood Disorders in Women, London, Martin Dunitz Ltd., 2000.

2. Yonkers KA, Little B (eds): The Management of Psychiatric Illness in Pregnancy, Chapman Hall Ltd., 2000.

3.  Yonkers KA, Davis LL:  Premenstrual Dysphoric Disorder. In Comprehensive Textbook of Psychiatry, Seventh Edition, Lippincott Williams & Wilkins, Vol II, pp.1952-1958, 2000.

4.  Howell H, Brawman-Mintzer O, Monnier J, Yonkers KA: Generalized Anxiety Disorder in Women, The Psychiatric Clinics of North America, Vol 24, pp.165-178, 2001.

5.  March D, Pearlstein T, Yonkers KA:  Treatment of Premenstrual Dysphoric Disorder, Psychiatric Clinics of North America: Annual of Drug Therapy, Vol 8, pp. 89-108, 2001.

6. Yonkers KA, Kidner CL: Sex Differences in Anxiety Disorders In Psychiatric Illness in Women. Edited by Lewis-Hall F, Williams T, Panetta J, Herrera J. Washington, D.C., American Psychiatric Publishing, 2002, pp 5-30.

7.  Shim J, Yonkers KA: Sertraline. In Textbook of Psychopharmacology. Edited by Schatzberg A, Nemeroff C. Washington, D.C., American Psychiatric Press, 2004, pp247-258.

8.  Yonkers KA, Brawman-Mintzer O: Women. In Handbook of Experimental Pharmacology: Antidepressants: Past, Present and Future, Volume 157, Chapter 13, 2004, pp 379-392.